More Than 430 Cases Now Filed in Federal GranuFlo Lawsuit Litigation, Bernstein Liebhard LLP Continues to Investigate Dialysis Claims
The Firm is eager to hear from dialysis patients who allegedly sustained the serious cardiovascular side effects associated with last year’s GranuFlo recall, and may now be eligible to file a claim.
New York, NY (PRWEB) December 22, 2013
GranuFlo lawsuit (http://www.thegranuflolawsuit.com/) claims continued to be filed this month in a federal litigation that now includes more than 430 cases over the recalled dialysis medications, according to Bernstein Liebhard LLP.
As per a Case List updated December 16th by the U.S. Judicial Panel on Multidistrict Litigation (JPML), a total of 433 lawsuits are now pending in in the U.S. District Court, District of Massachusetts. Cases filed in this federal proceeding similarly allege that heart attacks, strokes, sudden cardiac arrest and other life-threatening heart problems may result from use of GranuFlo and NaturaLyte, two acid concentrates manufactured by Fresenius Medical Care. Side effects from these drugs, which were used during dialysis treatments, generally occur within 72 hours of administration. According to lawsuits, Fresenius allegedly failed to warn about the fatal and near-fatal risks associated with its products, which were subject to a Class I recall by the U.S. Food and Drug Administration (FDA) in June 2012. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)
“We are looking forward to further progress in this litigation, as we continue to investigate legal claims brought by individuals affected by the GranuFlo recall,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and medications including GranuFlo and NaturaLyte. The Firm is offering free and confidential case evaluations to individuals who may have experienced strokes, heart attacks, sudden cardiac death and other cardiovascular problems stemming from these dialysis medications.
In addition to its growing Case List, the federal Massachusetts litigation is moving forward in other ways as well. Court documents indicate that parties involved in the proceeding have been directed to submit a Case Management Order addressing the process for selecting bellwether trials, as well as case specific discovery, by January 6, 2014.
In addition to the GranuFlo lawsuits now pending in Massachusetts federal court, a number of others have been transferred to a consolidated litigation underway in Massachusetts’ Middlesex County Superior Court. (In re: Consolidated Fresenius Cases, No. MICV2013-03400-O)
Claims against Fresenius also point to an internal memo sent by the company in November 2011 that noted 941 patient deaths occurring after use of GranuFlo and NaturaLyte. According to a New York Times report published shortly after the FDA's June 2012 recall of the medications, doctors outside the company’s network were not made aware of their potential to cause strokes, heart attacks and other serious heart problems until March 2012.* At that time, Fresenius issued an Urgent Product Notification that alerted the general public of the risks associated with its products. The Times article states that the FDA had begun investigating whether Fresenius violated federal laws by failing to notify physicians in all U.S. dialysis clinics using GranuFlo and NaturaLyte about the heart problems that may occur after use.
Individuals who may have sustained heart-related injuries within 72 hours of a dialysis treatment with GranuFlo or NaturaLyte may be entitled to compensation for damages incurred by their injuries. Find out more about the GranuFlo recall by visiting Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. To arrange for a free case review, please call 800-511-5092.
*nytimes.com/2012/06/15/health/fda-investigates-fresenius-for-failure-to-warn-of-risk.html; New York Times, June 14, 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
For the original version on PRWeb visit: http://www.prweb.com/releases/granuflo-lawsuit/granuflo-recall/prweb11441997.htm